Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent
1980-10-24
1982-01-26
Roberts, Elbert L.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
A01N 5726
Patent
active
043128602
ABSTRACT:
A synthetic protein-free lung surfactant composition is utilized to temporarily substitute for natural lung surfactant in the mammalian lung where such natural lung surfactant is absent or in low concentration. The synthetic surfactant composition consists essentially of a major amount of 1,2-dipalmitoyl-sn-3-glycerophosphoryl choline (DPPC), and a minor amount of a fatty alcohol, preferably a fatty alcohol having from 14 to 18 carbon atoms, and especially n-hexdecan-1-ol. The synthetic surfactant composition is administered directly into the lungs of a distressed subject to create a film on the alveolar interfacial surfaces and reduce surface tension. Expansion of the alveolar spaces is thereby facilitated.
REFERENCES:
patent: 3577446 (1971-05-01), Rakmit
patent: 4129650 (1978-12-01), Betzing et al.
Regents of the University of California
Roberts Elbert L.
LandOfFree
Lung surfactant compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lung surfactant compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lung surfactant compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1666613